Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of ZanubrutinibB-cell MalignanciesActive, not recruitingPhase 32026-08-28NCT04170283

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
BeOne Medicines76

153 results · Page 1 of 7

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aiiku HospitalSapporoJapan6
Albert Schweitzer ZiekenhuisNijmegenNetherlands2
Amsterdam Umc AmcAmsterdamNetherlands1
Aotearoa Clinical TrialsAucklandNew Zealand9
AOU Maggiore della CaritaNovaraItaly9
Aou Santa Maria Della Misericordia Di UdineUdineItaly2
Atlantic Health SystemMorristownUnited States17
Auckland City HospitalAucklandNew Zealand68
Austin HealthHeidelbergAustralia70
Azienda Ospedaliera Citta Della Salute E Della Scienza Di TorinoTorinoItaly3
Azienda Ospedaliera S Maria Di TerniTerniItaly2
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano NiguardaMilanItaly24
Banner Md Anderson Cancer CenterGilbertUnited States121
Barts Health NHS TrustLondonUnited Kingdom13
Barwon Health the Geelong HospitalGeelongAustralia2
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom39
Beijing Cancer HospitalBeijingChina208
Birmingham Heartlands HospitalBirminghamUnited Kingdom19
Border Medical OncologyEast AlburyAustralia2
Box Hill HospitalBox HillAustralia43
Brisbane Clinic For LymphomaGreenslopesAustralia1
Cabrini Hospital MalvernMalvernAustralia3
Calvary Mater NewcastleWaratahAustralia49
CARTI Cancer CenterLittle RockUnited States57
Centre de Lutte Contre Le Cancer Institut BergonieBordeauxFrance10